Cardiology

What if you could test the fit and function of a cardiac device in an exact replica of your patient's heart and head off complications before you start?

Paroxysmal atrial fibrillation is a first and only dx for some patients; for others it is just the beginning. What do you know about AF progression?

Newer anti-obesity drugs aren't your mother's Fen-Phen, but they also don't come without their own potential downsides.

Authors of a new study used data mining techniques to examine the risk associated with PPI use outside of high-risk cohorts.

Some things never change, or do they? Find answers here to key questions about the current state of high blood pressure treatment.

Diabetes, obesity, CVD-all have been linked to disruption of the day-night rhythm caused by shift work. More facts and some tips for your shift-weary patients, here.

Researchers discovered 16 new birth month–disease associations, more than half of them cardiovascular, contributing to better understanding of lifetime disease risk.

“Lower is better” regardless of the lipid-lowering agent used, publication confirms.

A new imaging study finds that more than one cocktail a day for seniors aged >75 years may do more harm than good.

About one-third of US adults have high blood pressure, the leading diagnosis in primary care. Find the latest news about advances in hypertension research in the pages that follow.

There is a razor edge differential between pharmacologic thrombus prevention and risk for excessive bleeding during procedures for AF. More guidance from a new study.

Hypertension, the “silent killer,” is the leading diagnosis in primary care, and several other circulatory disorders are bringing patients to your practice. Here are the particulars.

Like other pharmaceuticals, ACE inhibitors have their own adverse-effect profile. Find quick answers here to clinicians’ FAQs.

It’s time to rethink aspirin; there’s optimism about the PCSK9 inhibitors; and new help for people with valvular heart disease. What else is new in cardiology?

Guidelines say “no” to anticoagulation for young, otherwise healthy persons with atrial fibrillation. New research finds that clinical practice looks quite different.

No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?

Ablation therapy may be an option for these two patients with heart disease. What is your recommendation? And, does the evidence support it?

Stroke and TIA rates are down and fewer patients arrive by ambulance in national emergency department survey.

What does the patient with atrial fibrillation who would benefit from oral anticoagulation look like today? Q & A, here.

Results of the LEGACY study show long-term weight loss decreases AF burden and supports sustained sinus rhythm. A short slide show summarizes the 2015 ACC late-breaking abstract.

The patient drove himself to the ED after experiencing symptoms while playing basketball. He has a history of anxiety, but is this more than a case of nerves over a missed foul shot?

Be alert for the pitfalls in ECG interpretation of ACS. An initial tracing can be normal in about 10% of cases, even during chest pain. Nonspecific changes occur in another 5% to 15% of cases.

The answer might depend on which study group you ask-and when. Facts from 3 new analyses of testosterone in action are presented in the 7 slides that follow.